Taysha Gene Therapies Inc
Taysha Gene Therapies Inc (TSHA) Implied Volatility Current
TSHA implied volatility is 81%. IV Rank is 6%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking TSHA implied volatility helps you identify when options premiums on Taysha Gene Therapies Inc are historically cheap or expensive, and where the best trades are hiding. Taysha Gene Therapies Inc implied volatility reflects the market's expectation of future price movement: when TSHA IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Taysha Gene Therapies Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For TSHA, tracking metrics like TSHA IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on TSHA signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments.
The company was incorporated in 2019 and is based in Dallas, Texas.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where TSHA implied volatility sits today versus where it has been. Our scanner ranks Taysha Gene Therapies Inc implied volatility against its historical range, surfaces extremes in TSHA IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Taysha Gene Therapies Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 24, 2026
Trade options with IV on your side
Track TSHA IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→